MIR4756

gene
On this page

Also known as hsa-mir-4756

Summary

MIR4756 (microRNA 4756, HGNC:41529) is a microRNA gene on chromosome 20q13.2.

microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop.

Source: NCBI Gene 100616225 — RefSeq curated summary.

At a glance

  • Gene type: non-coding (miRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:41529
Approved symbolMIR4756
NamemicroRNA 4756
Location20q13.2
Locus typeRNA, micro
StatusApproved
Aliaseshsa-mir-4756
Ensembl geneENSG00000265595
Ensembl biotypemiRNA
Entrez100616225
RNAcentralURS000075E58C — miRNA, 78 nt, 1 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 miRNA

ENST00000577874

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

ENST00000577874 — 1 exons

ExonStartEnd
ENSE000026875135406840854068485

Expression profiles

Bgee: expression breadth broad, 26 present calls, max score 80.88.

Top tissues by expression

26 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
bloodUBERON:000017880.88gold quality
rectumUBERON:000105280.13gold quality
urinary bladderUBERON:000125574.15gold quality
stomachUBERON:000094572.30gold quality
tibial nerveUBERON:000132371.45gold quality
body of stomachUBERON:000116169.84gold quality
smooth muscle tissueUBERON:000113569.74gold quality
intestineUBERON:000016069.01gold quality
colonUBERON:000115568.32gold quality
transverse colonUBERON:000115767.81gold quality
lower esophagus muscularis layerUBERON:003583367.41gold quality
small intestineUBERON:000210866.69gold quality
gall bladderUBERON:000211066.42gold quality
minor salivary glandUBERON:000183066.21gold quality
small intestine Peyer’s patchUBERON:000345466.14gold quality
vaginaUBERON:000099664.99gold quality
fundus of stomachUBERON:000116064.65gold quality
esophagus mucosaUBERON:000246964.57gold quality
muscle layer of sigmoid colonUBERON:003580564.15gold quality
body of pancreasUBERON:000115064.11gold quality
prostate glandUBERON:000236762.11gold quality
skin of abdomenUBERON:000141661.57gold quality
thoracic mammary glandUBERON:000520059.97gold quality
upper lobe of left lungUBERON:000895257.50gold quality
Ammon’s hornUBERON:000195456.34gold quality
left testisUBERON:000453341.53gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.50

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 2)

  • In miRNA activity assays using the full-length hap.01 and hap.08 3’-UTR reporter vectors and follow-up validation experiments, hsa-miR-4324 and hsa-miR-4756-5p significantly reduced huntingtin gene (HTT) 3’-UTR reporter activity and endogenous HTT protein levels. (PMID:31296921)
  • Integrated network analysis identifies hsa-miR-4756-3p as a regulator of FOXM1 in Triple Negative Breast Cancer. (PMID:31554904)

Cross-species orthologs

0 orthologs

Protein

Non-coding RNA — no protein product; not a drug target.

Function

No curated pathway, Gene-Ontology, or interaction data.

Disease & clinical

No curated disease, variant, or cancer-driver associations.

Drugs & pharmacology

No drug or pharmacology data — not an established drug target.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.